[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fvzebfHuZOKyz2t__j6OTq7jhGL7um2wH7k0CdTiIWEs":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":6,"topConditions":11,"upcomingReadouts":32,"phaseBuckets":33,"rows":40},"Medacta International SA",[4],46,false,29,0,8867,[12,15,18,20,23,26,28,30],{"name":13,"count":14},"Avascular Necrosis",10,{"name":16,"count":17},"Traumatic Arthritis",7,{"name":19,"count":17},"Congenital Hip Dysplasia",{"name":21,"count":22},"Arthritis",6,{"name":24,"count":25},"Osteoarthritis",4,{"name":27,"count":25},"Rheumatoid Arthritis",{"name":29,"count":25},"Primary Osteoarthritis",{"name":31,"count":25},"Secondary Osteoarthritis",[],[34,35,36,37,38,39],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[]]